Ordaos Bio

Ordaōs Bio is a human-enabled, machine-driven drug design company founded in 2019. The company is dedicated to revolutionizing drug discovery by utilizing advanced technologies to design novel therapies that reduce patient suffering, particularly for overlooked patients. By leveraging a combination of human insight and machine learning, Ordaōs aims to create bespoke mini-proteins that facilitate the development of safer and more effective treatments.

The Ordaōs team collaborates closely with various biopharma partners and academic institutions, employing proprietary generative perception systems and reinforcement learning to evaluate billions of protein candidates virtually. This innovative approach not only accelerates the discovery process but also enhances the clinical success rates of new drug candidates. Ordaōs Bio's miniPRO™ proteins represent a significant advancement in the field, providing drug hunters with versatile and potent tools for therapeutic development. The company is on a mission to deliver novel therapies that significantly improve patient outcomes and contribute to the overall health landscape.